ARS Pharmaceuticals, Inc. SEC filings SPRY
ARS Pharmaceuticals, Inc. has 549 filings in SEC EDGAR's recent list, going back to Apr 12, 2016. Its latest annual report, Form ARS, was filed on Apr 29, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 5, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2026 | Nov 5, 2026 |
| 10-Q | Quarterly report | Aug 13, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 13, 2026 | Aug 13, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 17, 2026 | Jul 15, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 7, 2026 | Jul 6, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 25, 2026 | Jun 24, 2026 |
| 10-Q | Quarterly report | May 15, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
May 15, 2026 | May 15, 2026 |
| 8-K |
Current report
Officer or director change
|
May 13, 2026 | May 12, 2026 |
| ARS | Annual report to shareholders | Apr 29, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 29, 2026 | — |
| DEF 14A | Proxy statement | Apr 29, 2026 | Jun 24, 2026 |
| S-8 | Employee stock plan registration | Mar 9, 2026 | — |
| 10-K | Annual report | Mar 9, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 9, 2026 | Mar 9, 2026 |
| 10-Q | Quarterly report | Nov 10, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 10, 2025 | Nov 10, 2025 |
| 8-K |
Current report
Material agreement, New debt
|
Sep 29, 2025 | Sep 29, 2025 |
| 8-K |
Current report
Other events
|
Aug 28, 2025 | Aug 13, 2025 |
| 10-Q | Quarterly report | Aug 13, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 13, 2025 | Aug 13, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 26, 2025 | Jun 25, 2025 |
| 10-Q | Quarterly report | May 14, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Material agreement
|
May 2, 2025 | May 2, 2025 |
| ARS | Annual report to shareholders | Apr 29, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 29, 2025 | — |
| DEF 14A | Proxy statement | Apr 29, 2025 | Jun 25, 2025 |
| S-8 | Employee stock plan registration | Mar 20, 2025 | — |
| 10-K | Annual report | Mar 20, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 20, 2025 | Mar 20, 2025 |
| 8-K |
Current report
Other events
|
Mar 5, 2025 | Mar 5, 2025 |
| S-3ASR | Automatic shelf registration | Jan 31, 2025 | — |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 10-Q/A | Amended quarterly report | Dec 6, 2024 | Sep 30, 2024 |
| UPLOAD | Letter from the SEC | Nov 25, 2024 | — |
| CORRESP | Letter to the SEC | Nov 18, 2024 | — |
| 10-Q | Quarterly report | Nov 13, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Material agreement
|
Nov 12, 2024 | Nov 9, 2024 |
| UPLOAD | Letter from the SEC | Nov 7, 2024 | — |
| 8-K |
Current report
Material agreement
|
Oct 15, 2024 | Oct 8, 2024 |
| 8-K |
Current report
Material agreement
|
Sep 23, 2024 | Sep 17, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Aug 12, 2024 | Aug 9, 2024 |
| 10-Q | Quarterly report | Aug 6, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 28, 2024 | Jun 28, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 28, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 21, 2024 | Jun 20, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 10, 2024 | May 10, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| ARS | Annual report to shareholders | Apr 26, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 26, 2024 | — |
| DEF 14A | Proxy statement | Apr 26, 2024 | Jun 20, 2024 |
| S-8 | Employee stock plan registration | Mar 21, 2024 | — |
| 10-K | Annual report | Mar 21, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 21, 2024 | Mar 21, 2024 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Mar 7, 2024 | Mar 7, 2024 |
| 10-Q | Quarterly report | Nov 9, 2023 | Sep 30, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 25, 2023 | Sep 25, 2023 |
| 8-K |
Current report
Other events
|
Sep 20, 2023 | Sep 19, 2023 |
| 10-Q | Quarterly report | Aug 10, 2023 | Jun 30, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 10, 2023 | Aug 10, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 28, 2023 | Jun 27, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 16, 2023 | May 16, 2023 |
| 10-Q | Quarterly report | May 15, 2023 | Mar 31, 2023 |
| 8-K |
Current report
Results of operations
|
May 15, 2023 | May 15, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
May 9, 2023 | May 9, 2023 |
| EFFECT | Filing | May 3, 2023 | — |
| CORRESP | Letter to the SEC | May 1, 2023 | — |
| ARS | Annual report to shareholders | May 1, 2023 | Dec 31, 2022 |
| DEFA14A | Additional proxy material | May 1, 2023 | — |
| DEF 14A | Proxy statement | May 1, 2023 | Jun 27, 2023 |
| UPLOAD | Letter from the SEC | Apr 24, 2023 | — |
| S-3 | Shelf registration | Apr 20, 2023 | — |
| 10-K | Annual report | Mar 23, 2023 | Dec 31, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 23, 2023 | Mar 23, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 13, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended
|
Feb 22, 2023 | Feb 22, 2023 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Feb 14, 2023 | Feb 14, 2023 |
| 8-K/A | Amended current report | Jan 17, 2023 | Nov 4, 2022 |
| S-8 | Employee stock plan registration | Jan 17, 2023 | — |
| 8-K |
Current report
Officer or director change
|
Dec 9, 2022 | Dec 6, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 6, 2022 | Dec 6, 2022 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Change in control, Officer or director change, Bylaw or fiscal year change, Shareholder vote results, Other events
|
Nov 8, 2022 | Nov 4, 2022 |
| 10-Q | Quarterly report | Nov 2, 2022 | Sep 30, 2022 |
| DEFA14A | Additional proxy material | Nov 2, 2022 | — |
| 8-K |
Current report
Other events
|
Nov 2, 2022 | Nov 1, 2022 |
| DEFA14A | Additional proxy material | Oct 27, 2022 | — |
| DEFA14A | Additional proxy material | Oct 27, 2022 | — |
| 8-K |
Current report
Material agreement
|
Oct 27, 2022 | Oct 25, 2022 |
| DEFA14A | Additional proxy material | Oct 21, 2022 | — |
| 8-K |
Current report
Other events
|
Oct 21, 2022 | Oct 21, 2022 |
| UPLOAD | Letter from the SEC | Oct 7, 2022 | — |
| DEFM14A | Filing | Oct 6, 2022 | — |
| 8-K |
Current report
Material agreement, Agreement ended
|
Sep 30, 2022 | Sep 27, 2022 |
| CORRESP | Letter to the SEC | Sep 16, 2022 | — |
| PRER14A | Filing | Sep 16, 2022 | — |
| UPLOAD | Letter from the SEC | Sep 9, 2022 | — |
| 8-K |
Current report
Officer or director change
|
Sep 2, 2022 | Sep 1, 2022 |
| PREM14A | Filing | Aug 11, 2022 | Aug 11, 2022 |
| 10-Q | Quarterly report | Aug 11, 2022 | Jun 30, 2022 |
| DEFA14A | Additional proxy material | Jul 21, 2022 | — |
| 8-K |
Current report
Material agreement, Exit or restructuring costs, Officer or director change, Other events
|
Jul 21, 2022 | Jul 21, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2022 | Jun 10, 2022 |
| 10-Q | Quarterly report | May 12, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Results of operations
|
May 12, 2022 | May 12, 2022 |
| 8-K |
Current report
Agreement ended
|
May 6, 2022 | May 2, 2022 |
| DEFA14A | Additional proxy material | Apr 28, 2022 | — |
| DEF 14A | Proxy statement | Apr 28, 2022 | Jun 10, 2022 |
| 10-K | Annual report | Mar 31, 2022 | Dec 31, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 31, 2022 | Mar 31, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 17, 2022 | Mar 11, 2022 |
| EFFECT | Filing | Jan 13, 2022 | — |
| CORRESP | Letter to the SEC | Jan 11, 2022 | — |
| UPLOAD | Letter from the SEC | Jan 10, 2022 | — |
| S-8 | Employee stock plan registration | Jan 3, 2022 | — |
| S-3 | Shelf registration | Jan 3, 2022 | — |
| 10-Q | Quarterly report | Nov 10, 2021 | Sep 30, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2021 | Nov 10, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 16, 2021 | Sep 16, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 13, 2021 | Sep 13, 2021 |
| 10-Q | Quarterly report | Aug 12, 2021 | Jun 30, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2021 | Aug 12, 2021 |
| 8-K |
Current report
Material agreement, New debt
|
Jul 2, 2021 | Jul 1, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 9, 2021 | Jun 4, 2021 |
| 10-Q | Quarterly report | May 13, 2021 | Mar 31, 2021 |
| 8-K |
Current report
Results of operations
|
May 13, 2021 | May 13, 2021 |
| DEFA14A | Additional proxy material | Apr 22, 2021 | — |
| DEF 14A | Proxy statement | Apr 22, 2021 | Jun 4, 2021 |
| S-8 | Employee stock plan registration | Mar 29, 2021 | — |
| 10-K | Annual report | Mar 29, 2021 | Dec 31, 2020 |
| 8-K |
Current report
Results of operations
|
Mar 29, 2021 | Mar 29, 2021 |
| 8-K |
Current report
Officer or director change
|
Mar 15, 2021 | Mar 12, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Dec 8, 2020 | Dec 8, 2020 |
| S-8 | Employee stock plan registration | Dec 4, 2020 | — |
| 424B4 | Prospectus | Dec 4, 2020 | — |
| EFFECT | Filing | Dec 3, 2020 | — |
| S-1MEF | Filing | Dec 3, 2020 | — |
| SEC STAFF LETTER | Filing | Dec 3, 2020 | — |
| CERT | Filing | Dec 3, 2020 | — |
| S-1/A | Amended registration statement | Dec 3, 2020 | — |
| CORRESP | Letter to the SEC | Dec 1, 2020 | — |
| CORRESP | Letter to the SEC | Dec 1, 2020 | — |
| 8-A12B | Filing | Dec 1, 2020 | — |
| CORRESP | Letter to the SEC | Nov 30, 2020 | — |
| S-1/A | Amended registration statement | Nov 30, 2020 | — |
| UPLOAD | Letter from the SEC | Nov 27, 2020 | — |
| CORRESP | Letter to the SEC | Nov 18, 2020 | — |
| CORRESP | Letter to the SEC | Nov 10, 2020 | — |
| S-1 | Registration statement | Nov 10, 2020 | — |
| SEC STAFF LETTER | Filing | Oct 30, 2020 | — |
| UPLOAD | Letter from the SEC | Oct 29, 2020 | — |
| D | Filing | Oct 6, 2020 | — |
| DRS | Filing | Oct 2, 2020 | — |
| D | Filing | Mar 19, 2020 | — |
| D | Filing | Sep 20, 2018 | — |
| D | Filing | Jan 8, 2018 | — |
| D/A | Filing | Feb 6, 2017 | — |
| D | Filing | Nov 30, 2016 | — |
| D | Filing | Apr 12, 2016 | — |
| D | Filing | Apr 12, 2016 | — |
Showing 165 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- SPRY (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- San Diego, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1671858
- Former names
- Silverback Therapeutics, Inc. (until Nov 8, 2022)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.